ArticleScientific reports2026
Hydrothermal synthesis and optimization of hierarchical copper molybdate nanostructures for photocatalytic degradation of crystal violet and antimicrobial applications.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Synthesis and photocatalytic activity of CeOFrontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, the Hierarchical Copper Molybdate Nanostructures (HCM) photocatalyst was synthesized via a hydrothermal method and characterized using XRD, FTIR, UV-vis spectroscopy, SEM, TEM, and EDX analyses, confirming the formation of hierarchical nanocrystalline structures with a direct band gap of ~ 2.4 eV. The photocatalytic performance of HCM was systematically evaluated for the degradation of crystal violet (CV) dye under UV irradiation. Experimental design and process optimization were conducted using response surface method (RSM) and ANOVA, which demonstrated that pH, irradiation time, and catalyst dosage were the most influential variables, whereas dye concentration exerted a minor effect. Under optimized conditions (pH 10, 60 min, 15 mg/L CV, and 20 mg catalyst dosage), more than 99% CV dye degradation was achieved. Kinetic analysis demonstrated that the degradation followed a pseudo-first-order model, while thermodynamic studies indicated that the process is spontaneous, endothermic, and entropy-driven. Mechanistic evaluation confirmed that reactive oxygen species (·OH, O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.